-
Azzeh M, Honigman A, Taraboulos A, Rouvinski A, Wolf DG, 2006: Structural changes in human cytomegalovirus cytoplasmic assembly sites in the absence of UL97 kinase activity[J]. Virology, 354, 69-79. doi: 10.1016/j.virol.2006.05.037
-
Biron KK, Fyfe JA, Stanat SC, Leslie LK, Sorrell JB, Lambe CU, Coen DM, 1986: A human cytomegalovirus mutant resistant to the nucleoside analog 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine (BW B759U) induces reduced levels of BW B759U triphosphate[J]. Proc Natl Acad Sci U S A, 83, 8769-8773. doi: 10.1073/pnas.83.22.8769
-
Britt B (2007) Maturation and egress. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge. Chapter 20
-
Budin I, Devaraj NK, 2012: Membrane assembly driven by a biomimetic coupling reaction[J]. J Am Chem Soc, 134, 751-753. doi: 10.1021/ja2076873
-
Bustin S, 2015: Molecular Biology of the Cell, Sixth Edition ISBN: 9780815344643 and Molecular Biology of the Cell, Sixth Edition, The Problems Book[J]. Int J Mol Sci, 16, 28123-28125. doi: 10.3390/ijms161226074
-
Chan D, Zheng Y, Tyner JW, Chng WJ, Chien WW, Gery S, Leong G, Braunstein GD, Koeffler HP, 2013: Belinostat and panobinostat (HDACI): in vitro and in vivo studies in thyroid cancer[J]. J Cancer Res Clin Oncol, 139, 1507-1514. doi: 10.1007/s00432-013-1465-6
-
Chou S, 1999: Antiviral drug resistance in human cytomegalovirus[J]. Transpl Infect Dis, 1, 105-114. doi: 10.1034/j.1399-3062.1999.010204.x
-
Ciferri C, Chandramouli S, Leitner A, Donnarumma D, Cianfrocco MA, Gerrein R, Friedrich K, Aggarwal Y, Palladino G, Aebersold R, Norais N, Settembre EC, Carfi A, 2015: Antigenic characterization of the HCMV gH/gL/gO and pentamer cell entry complexes reveals binding sites for potently neutralizing human antibodies[J]. PLoS Pathog, 11, e1005230-. doi: 10.1371/journal.ppat.1005230
-
Coe NR, Simpson MA, Bernlohr DA, 1999: Targeted disruption of the adipocyte lipid-binding protein (aP2 protein) gene impairs fat cell lipolysis and increases cellular fatty acid levels[J]. J Lipid Res, 40, 967-972. doi: 10.1016/S0022-2275(20)32133-7
-
Compton T, Feire A (2007) Early events in human cytomegalovirus infection. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge. Chapter 16
-
Daigle D, Gradoville L, Tuck D, Schulz V, Wang'ondu R, Ye J, Gorres K, Miller G, 2011: Valproic acid antagonizes the capacity of other histone deacetylase inhibitors to activate the Epstein-barr virus lytic cycle[J]. J Virol, 85, 5628-5643. doi: 10.1128/JVI.02659-10
-
Davison AJ, Bhella D (2007) Comparative genome and virion structure. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge. Chapter 14
-
Davison AJ, Dolan A, Akter P, Addison C, Dargan DJ, Alcendor DJ, McGeoch DJ, Hayward GS, 2003: The human cytomegalovirus genome revisited: comparison with the chimpanzee cytomegalovirus genome[J]. J Gen Virol, 84, 17-28. doi: 10.1099/vir.0.18606-0
-
de Veer MJ, Holko M, Frevel M, Walker E, Der S, Paranjape JM, Silverman RH, Williams BR, 2001: Functional classification of interferon-stimulated genes identified using microarrays[J]. J Leukoc Biol, 69, 912-920.
-
Gandhi MK, Khanna R, 2004: Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments[J]. Lancet Infect Dis, 4, 725-738. doi: 10.1016/S1473-3099(04)01202-2
-
Grey F, Antoniewicz A, Allen E, Saugstad J, McShea A, Carrington JC, Nelson J, 2005: Identification and characterization of human cytomegalovirus-encoded microRNAs[J]. J Virol, 79, 12095-12099. doi: 10.1128/JVI.79.18.12095-12099.2005
-
Gupta M, Ansell SM, Novak AJ, Kumar S, Kaufmann SH, Witzig TE, 2009: Inhibition of histone deacetylase overcomes rapamycin-mediated resistance in diffuse large B-cell lymphoma by inhibiting Akt signaling through mTORC2[J]. Blood, 114, 2926-2935.
-
Haque SJ, Williams BR, 1998: Signal transduction in the interferon system[J]. Semin Oncol, 25, 14-22.
-
Harjes U, Bridges E, McIntyre A, Fielding BA, Harris AL, 2014: Fatty acid-binding protein 4, a point of convergence for angiogenic and metabolic signaling pathways in endothelial cells[J]. J Biol Chem, 289, 23168-23176. doi: 10.1074/jbc.M114.576512
-
Inoue S, Walewska R, Dyer MJ, Cohen GM, 2008: Downregulation of Mcl-1 potentiates HDACi-mediated apoptosis in leukemic cells[J]. Leukemia, 22, 819-825. doi: 10.1038/leu.2008.1
-
Jean Beltran PM, Cristea IM, 2014: The life cycle and pathogenesis of human cytomegalovirus infection: lessons from proteomics[J]. Expert Rev Proteomics, 11, 697-711. doi: 10.1586/14789450.2014.971116
-
Klase Z, Yedavalli VS, Houzet L, Perkins M, Maldarelli F, Brenchley J, Strebel K, Liu P, Jeang KT, 2014: Activation of HIV-1 from latent infection via synergy of RUNX1 inhibitor Ro5-3335 and SAHA[J]. PLoS Pathog, 10, e1003997-. doi: 10.1371/journal.ppat.1003997
-
Kotton CN, 2010: Management of cytomegalovirus infection in solid organ transplantation[J]. Nat Rev Nephrol, 6, 711-721. doi: 10.1038/nrneph.2010.141
-
Koyuncu E, Purdy JG, Rabinowitz JD, Shenk T, 2013: Saturated Very Long Chain Fatty Acids Are Required for the Production of Infectious Human Cytomegalovirus Progeny[J]. Plos Pathogens, 9, e1003333-. doi: 10.1371/journal.ppat.1003333
-
Lurain NS, Chou S, 2010: Antiviral drug resistance of human cytomegalovirus[J]. Clin Microbiol Rev, 23, 689-712. doi: 10.1128/CMR.00009-10
-
Michaelis M, Kohler N, Reinisch A, Eikel D, Gravemann U, Doerr HW, Nau H, Cinatl J Jr, 2004: Increased human cytomegalovirus replication in fibroblasts after treatment with therapeutical plasma concentrations of valproic acid[J]. Biochem Pharmacol, 68, 531-538. doi: 10.1016/j.bcp.2004.04.013
-
Michaelis M, Suhan T, Reinisch A, Reisenauer A, Fleckenstein C, Eikel D, Gumbel H, Doerr HW, Nau H, Cinatl J Jr, 2005: Increased replication of human cytomegalovirus in retinal pigment epithelial cells by valproic acid depends on histone deacetylase inhibition[J]. Invest Ophthalmol Vis Sci, 46, 3451-3457. doi: 10.1167/iovs.05-0369
-
Mocarski Jr E (2007) Betaherpes viral genes and their functions. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge. Chapter 15
-
Munger J, Bennett BD, Parikh A, Feng XJ, McArdle J, Rabitz HA, Shenk T, Rabinowitz JD, 2008: Systems-level metabolic flux profiling identifies fatty acid synthesis as a target for antiviral therapy[J]. Nat Biotechnol, 26, 1179-1186. doi: 10.1038/nbt.1500
-
Murphy E, Rigoutsos I, Shibuya T, Shenk TE, 2003: Reevaluation of human cytomegalovirus coding potential[J]. Proc Natl Acad Sci U S A, 100, 13585-13590. doi: 10.1073/pnas.1735466100
-
O'Connor CM, Nukui M, Gurova KV, Murphy EA, 2016: Inhibition of the Facilitates Chromatin Transcription (FACT) complex reduces transcription from the HCMV MIEP in models of lytic and latent replication[J]. J Virol, 90, 4249-4253. doi: 10.1128/JVI.02501-15
-
Penfold ME, Mocarski ES, 1997: Formation of cytomegalovirus DNA replication compartments defined by localization of viral proteins and DNA synthesis[J]. Virology, 239, 46-61. doi: 10.1006/viro.1997.8848
-
Pereira L, Maidji E, Fisher SJ, McDonagh S, Tabata T (2007) HCMV persistence in the population: potential transplacental transmission. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge. Chapter 45
-
Purdy JG, Shenk T, Rabinowitz JD, 2015: Fatty acid elongase 7 catalyzes lipidome remodeling essential for human cytomegalovirus replication[J]. Cell Rep, 10, 1375-1385. doi: 10.1016/j.celrep.2015.02.003
-
Sakamoto E, Hato F, Kato T, Sakamoto C, Akahori M, Hino M, Kitagawa S, 2005: Type Ⅰ and type Ⅱ interferons delay human neutrophil apoptosis via activation of STAT3 and up-regulation of cellular inhibitor of apoptosis 2[J]. J Leukoc Biol, 78, 301-309. doi: 10.1189/jlb.1104690
-
Sato A, Saito Y, Sugiyama K, Sakasegawa N, Muramatsu T, Fukuda S, Yoneya M, Kimura M, Ebinuma H, Hibi T, Ikeda M, Kato N, Saito H, 2013: Suppressive effect of the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) on hepatitis C virus replication[J]. J Cell Biochem, 114, 1987-1996. doi: 10.1002/jcb.24541
-
Schroer J, Shenk T, 2008: Inhibition of cyclooxygenase activity blocks cell-to-cell spread of human cytomegalovirus[J]. Proc Natl Acad Sci U S A, 105, 19468-19473. doi: 10.1073/pnas.0810740105
-
Seo JY, Cresswell P, 2013: Viperin regulates cellular lipid metabolism during human cytomegalovirus infection[J]. PLoS Pathog, 9, e1003497-. doi: 10.1371/journal.ppat.1003497
-
Sharma M, Bender BJ, Kamil JP, Lye MF, Pesola JM, Reim NI, Hogle JM, Coen DM, 2015: Human cytomegalovirus UL97 phosphorylates the viral nuclear egress complex[J]. J Virol, 89, 523-. doi: 10.1128/JVI.02426-14
-
Stern-Ginossar N, Weisburd B, Michalski A, Le VT, Hein MY, Huang SX, Ma M, Shen B, Qian SB, Hengel H, Mann M, Ingolia NT, Weissman JS, 2012: Decoding human cytomegalovirus[J]. Science, 338, 1088-1093. doi: 10.1126/science.1227919
-
Sullivan V, Talarico CL, Stanat SC, Davis M, Coen DM, Biron KK, 1992: A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells[J]. Nature, 359, 85-. doi: 10.1038/359085a0
-
Thiagalingam S, Cheng KH, Lee HJ, Mineva N, Thiagalingam A, Ponte JF, 2003: Histone deacetylases: unique players in shaping the epigenetic histone code[J]. Ann N Y Acad Sci, 983, 84-100. doi: 10.1111/j.1749-6632.2003.tb05964.x
-
Van Damme E, 2015: Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D plus R plus liver transplant patients[J]. J Gen Virol, 96, 131-143. doi: 10.1099/vir.0.069872-0
-
Viswanathan K, Smith MS, Malouli D, Mansouri M, Nelson JA, Fruh K, 2011: BST2/Tetherin enhances entry of human cytomegalovirus[J]. PLoS Pathog, 7, e1002332-. doi: 10.1371/journal.ppat.1002332
-
Wang YC, Yang X, Xing LH, Kong WZ, 2013: Effects of SAHA on proliferation and apoptosis of hepatocellular carcinoma cells and hepatitis B virus replication[J]. World J Gastroenterol, 19, 5159-5164. doi: 10.3748/wjg.v19.i31.5159
-
White EA, Spector DH (2007) Early viral gene expression and function. In: Arvin A, Campadelli-Fiume G, Mocarski E, Moore PS, Roizman B, Whitley R, Yamanishi K (eds) Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Cambridge. Chapter 16
-
Xie M, Xuan B, Shan J, Pan D, Sun Y, Shan Z, Zhang J, Yu D, Li B, Qian Z, 2015: Human cytomegalovirus exploits interferon-induced transmembrane proteins to facilitate morphogenesis of the virion assembly compartment[J]. J Virol, 89, 3049-3061. doi: 10.1128/JVI.03416-14
-
Yang Y, Zhao Y, Liao W, Yang J, Wu L, Zheng Z, Yu Y, Zhou W, Li L, Feng J, Wang H, Zhu WG, 2009: Acetylation of FoxO1 activates Bim expression to induce apoptosis in response to histone deacetylase inhibitor depsipeptide treatment[J]. Neoplasia, 11, 313-324. doi: 10.1593/neo.81358
-
Zhou Q, Agoston AT, Atadja P, Nelson WG, Davidson NE, 2008: Inhibition of histone deacetylases promotes ubiquitin-dependent proteasomal degradation of DNA methyltransferase 1 in human breast cancer cells[J]. Mol Cancer Res, 6, 873-883. doi: 10.1158/1541-7786.MCR-07-0330
-
Zhu H, Cong JP, Yu D, Bresnahan WA, Shenk TE, 2002: Inhibition of cyclooxygenase 2 blocks human cytomegalovirus replication[J]. Proc Natl Acad Sci U S A, 99, 3932-3937. doi: 10.1073/pnas.052713799
-
Zhuravskaya T, Maciejewski JP, Netski DM, Bruening E, Mackintosh FR, St Jeor S, 1997: Spread of human cytomegalovirus (HCMV) after infection of human hematopoietic progenitor cells: model of HCMV latency[J]. Blood, 90, 2482-2491. doi: 10.1182/blood.V90.6.2482